A new OCVA-led clinical trial explores time-restricted eating’s potential to improve mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease patients through circadi...
New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June 2...
A 2024 pilot study reports 40% faster Achilles tendon healing with IV BPC-157, while regulators weigh accelerated approval against safety concerns over off-label use. New clinical data on intravenous ...
A 2023 ocva.eu study reveals frozen konjac glucomannan reduces visceral fat by 18% and improves insulin sensitivity in obese mice, outperforming sol and gel forms through enhanced prebiotic effects. R...
Recent clinical trials demonstrate targeted dietary interventions and pharmacogenomic testing significantly improve side effect management and treatment adherence for breast cancer patients on endocri...
Breakthrough NLC formulations enhance bioavailability of curcumin and EGCG, demonstrating 40% wrinkle reduction through dual collagen protection and SIRT1 activation, per 2024 clinical trials. Recent ...
New studies reveal Curcuma kwangsiensis radix’s antiplatelet properties via three novel sesquiterpenoids, with AI models predicting thrombin inhibition and WHO endorsing standardized research. B...
Recent studies demonstrate herbal cubosomes enhance bioavailability of arthritis treatments by 40%, with clinical trials and industry partnerships paving the way for commercialization by 2026. Advance...
Emerging plant-based histological stains demonstrate comparable efficacy to synthetic counterparts while reducing toxic waste and aligning with new EU solvent restrictions. June 2024 regulatory shifts...
Combined turmeric-ginger supplementation reduces inflammatory markers by 32%, per 2024 clinical trials. European rheumatology experts now endorse culinary doses as complementary therapy alongside enha...
